In 2009, NCI consolidated its anticancer drug discovery and development resources in support of a robust, balanced, goal-driven therapeutics pipeline--the NCI Experimental Therapeutics (NExT) Program. For more information about this new initiative, including how to submit an application, please visit the NExT website.